Stories

Nicotine pouches sit at the intersection of science and politics — and the two are not always moving in the same direction. Evidence can help distinguish smoke-free products from cigarettes, but political pressure often pushes them into the same moral category. That contrast matters because regulation shaped by fear may ignore differences in exposure, risk and use. The battle over pouches is ultimately a test of whether policy can follow evidence when the politics becomes uncomfortable.

When parliament starts taking tobacco harm reduction seriously, the conversation changes. The focus can move beyond slogans about nicotine and towards the harder question of how to reduce smoking-related disease in practice. South Africa has an opportunity to build regulation that recognises the difference between combustible tobacco and lower-risk alternatives. Discovery is only the first step — the test is whether lawmakers turn evidence into proportionate policy.

Harm reduction cannot only reach the people easiest to reach. Marginalised communities often face the highest burden of smoking-related harm, while also having less access to trusted healthcare, stable support and practical quitting routes. Tobacco harm reduction has to be built with those realities in mind: affordable options, credible messengers and policies that do not add stigma to disadvantage. Reducing harm means reaching the people public health too often misses.

A smoking ban may look like a clean public health victory, but bans rarely stay simple once they meet real life. Adults who smoke are still adults, and policy has to balance harm reduction with autonomy, enforcement and unintended consequences. The better question is not how far restrictions can go, but whether they actually reduce smoking-related harm without pushing people into stigma, avoidance or less visible use. Public health should persuade, support and reduce risk — not rely on prohibition as its default language.

A 74% fall in youth vaping changes the way the problem should be described. If use is declining sharply, the “epidemic” label may no longer reflect the evidence — and policy should adapt accordingly. Youth access still requires enforcement, but exaggerating the scale of the issue can distort public perception and justify restrictions that also harm adult smokers. Good public health depends on accurate labels, not outdated alarm.

Heat is no longer an abstract climate issue when people are trying to sleep, work or stay safe in homes built for a cooler past. The air-conditioning debate shows how quickly adaptation becomes political: some see cooling as wasteful, others as basic protection against extreme heat. A serious response should not shame people for needing relief, but make cooling cleaner, more efficient and more accessible. Climate policy has to help people live with the risks already here, not only argue about the emissions still to come.

A regulation that treats every nicotine product as equally dangerous starts from the wrong premise. South Africa’s tobacco policy should recognise that the greatest harm comes from combustion, not nicotine itself. Risk-proportionate regulation would still control access, protect young people and set product standards, but it would not make lower-risk alternatives harder to use than cigarettes. The aim should be to move smokers down the risk continuum, not trap them at the most harmful end.

Power, temperature and device design are often discussed as if they automatically translate into higher danger. With sub-ohm vaping, the more important question is what the evidence actually shows about emissions, exposure and real-world use. High-powered devices should be assessed carefully, but not through assumptions that ignore how experienced users control settings, airflow and liquid consumption. Safety debates need measurements, context and comparison with the risks of continued smoking.